Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.670
0.00 (0.00%)
At close: Oct 7, 2026, 4:00 PM EDT
1.651
-0.019 (-1.17%)
After-hours: Oct 7, 2026, 7:30 PM EDT
Gain Therapeutics Employees
As of December 31, 2025, Gain Therapeutics had 21 total employees, including 20 full-time and 1 part-time employees. The number of employees decreased by 4 or -16.00% compared to the previous year. That makes Gain Therapeutics the world's 38,070th largest employer and 5,480th in the United States.
Employees
21
Change (1Y)
-4
Growth (1Y)
-16.00%
Revenue / Employee
n/a
Profits / Employee
-$957,441
Market Cap
72.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -4 | -16.00% | 20 | 1 |
| Dec 31, 2024 | 25 | -7 | -21.88% | 23 | 2 |
| Dec 31, 2023 | 32 | 1 | 3.23% | 29 | 3 |
| Dec 31, 2022 | 31 | 2 | 6.90% | 28 | 3 |
| Dec 31, 2021 | 29 | 15 | 107.14% | 25 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| MindWalk Holdings | 77 |
| Verrica Pharmaceuticals | 76 |
| Oncolytics Biotech | 29 |
| Spero Therapeutics | 25 |
| Cingulate | 14 |
| MAIA Biotechnology | 13 |
| Rein Therapeutics | 10 |
GANX News
- 6 days ago - Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration - GlobeNewsWire
- 8 days ago - Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson's Disease and Movement Disorders - GlobeNewsWire
- 20 days ago - Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference - GlobeNewsWire
- 6 weeks ago - Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 1 month ago - Gain Therapeutics Earnings release: Q2 2026 - Filings
- 1 month ago - Gain Therapeutics Quarterly report: Q2 2026 - Filings
- 1 month ago - Gain Therapeutics reports Q2 EPS (11c), consensus (15c) - TheFly
- 2 months ago - Gain Therapeutics Slides: Corporate presentation - Filings